BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 30905287)

  • 1. A matter of background: DNA repair pathways as a possible cause for the sparse distribution of CRISPR-Cas systems in bacteria.
    Bernheim A; Bikard D; Touchon M; Rocha EPC
    Philos Trans R Soc Lond B Biol Sci; 2019 May; 374(1772):20180088. PubMed ID: 30905287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of bacterial mutation rate on the evolution of CRISPR-Cas adaptive immunity.
    Chevallereau A; Meaden S; van Houte S; Westra ER; Rollie C
    Philos Trans R Soc Lond B Biol Sci; 2019 May; 374(1772):20180094. PubMed ID: 30905293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CRISPR-Cas: Complex Functional Networks and Multiple Roles beyond Adaptive Immunity.
    Faure G; Makarova KS; Koonin EV
    J Mol Biol; 2019 Jan; 431(1):3-20. PubMed ID: 30193985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of NHEJ repair by type II-A CRISPR-Cas systems in bacteria.
    Bernheim A; Calvo-Villamañán A; Basier C; Cui L; Rocha EPC; Touchon M; Bikard D
    Nat Commun; 2017 Dec; 8(1):2094. PubMed ID: 29234047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Why so rare if so essentiel: the determinants of the sparse distribution of CRISPR-Cas systems in bacterial genomes].
    Bernheim A
    Biol Aujourdhui; 2017; 211(4):255-264. PubMed ID: 29956652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CRISPR-Cas adaptive immunity and the three Rs.
    Killelea T; Bolt EL
    Biosci Rep; 2017 Aug; 37(4):. PubMed ID: 28674106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phylogenomics of Cas4 family nucleases.
    Hudaiberdiev S; Shmakov S; Wolf YI; Terns MP; Makarova KS; Koonin EV
    BMC Evol Biol; 2017 Nov; 17(1):232. PubMed ID: 29179671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CRISPR-Cas immunity, DNA repair and genome stability.
    Cubbon A; Ivancic-Bace I; Bolt EL
    Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30209206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Origins and evolution of CRISPR-Cas systems.
    Koonin EV; Makarova KS
    Philos Trans R Soc Lond B Biol Sci; 2019 May; 374(1772):20180087. PubMed ID: 30905284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single-Strand Annealing Plays a Major Role in Double-Strand DNA Break Repair following CRISPR-Cas9 Cleavage in
    Zhang WW; Matlashewski G
    mSphere; 2019 Aug; 4(4):. PubMed ID: 31434745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The physicist's guide to one of biotechnology's hottest new topics: CRISPR-Cas.
    Bonomo ME; Deem MW
    Phys Biol; 2018 Apr; 15(4):041002. PubMed ID: 29543191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of CRISPR-Cas adaptive immune systems.
    Patterson AG; Yevstigneyeva MS; Fineran PC
    Curr Opin Microbiol; 2017 Jun; 37():1-7. PubMed ID: 28359988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insertion sequences in the CRISPR-Cas system regulate horizontal antimicrobial resistance gene transfer in Shigella strains.
    Chen S; Liu H; Liang W; Hong L; Zhang B; Huang L; Guo X; Duan G
    Int J Antimicrob Agents; 2019 Feb; 53(2):109-115. PubMed ID: 30290202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The CRISPR-Cas Immune System and Genetic Transfers: Reaching an Equilibrium.
    Samson JE; Magadan AH; Moineau S
    Microbiol Spectr; 2015 Feb; 3(1):PLAS-0034-2014. PubMed ID: 26104549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CRISPR-Cas: New Tools for Genetic Manipulations from Bacterial Immunity Systems.
    Jiang W; Marraffini LA
    Annu Rev Microbiol; 2015; 69():209-28. PubMed ID: 26209264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA and RNA interference mechanisms by CRISPR-Cas surveillance complexes.
    Plagens A; Richter H; Charpentier E; Randau L
    FEMS Microbiol Rev; 2015 May; 39(3):442-63. PubMed ID: 25934119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Why put up with immunity when there is resistance: an excursion into the population and evolutionary dynamics of restriction-modification and CRISPR-Cas.
    Gurney J; Pleška M; Levin BR
    Philos Trans R Soc Lond B Biol Sci; 2019 May; 374(1772):20180096. PubMed ID: 30905282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Harnessing CRISPR-Cas systems for bacterial genome editing.
    Selle K; Barrangou R
    Trends Microbiol; 2015 Apr; 23(4):225-32. PubMed ID: 25698413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Advances in molecular mechanisms of adaptive immunity mediated by type I-E CRISPR/Cas system--A review].
    Sun D; Qiu J
    Wei Sheng Wu Xue Bao; 2016 Jan; 56(1):1-7. PubMed ID: 27305774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genome-wide correlation analysis suggests different roles of CRISPR-Cas systems in the acquisition of antibiotic resistance genes in diverse species.
    Shehreen S; Chyou TY; Fineran PC; Brown CM
    Philos Trans R Soc Lond B Biol Sci; 2019 May; 374(1772):20180384. PubMed ID: 30905286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.